A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Local Institution - 0009, Beijing

Local Institution - 0004, Shenyang

Local Institution - 0021, Shenyang

Local Institution - 0003, Changchun

Local Institution - 0013, Harbin

Local Institution - 0001, Shanghai

Local Institution - 0015, Yangzhou

Local Institution - 0037, Jinan

Local Institution - 0030, Qingdao

Local Institution - 0007, Tianjin

Local Institution - 0018, Tianjin

Local Institution - 0014, Hangzhou

Local Institution - 0020, Hangzhou

Local Institution - 0012, Ningbo

Local Institution - 0016, Ningbo

Local Institution - 0005, Changsha

Local Institution - 0023, Wuhan

Local Institution - 0006, Zhengzhou

Local Institution - 0029, Chengdu

Local Institution - 0010, Kunming

Local Institution - 0033, Taiyuan